Literature DB >> 23923635

An improved assay for the detection of alterations in bacterial DNA supercoiling in vivo.

M Abu Mraheil1, A Heisig, P Heisig.   

Abstract

Due to the increasing prevalence of antibiotic resistance and the yet low output of the genomics-based drug discovery approach novel strategies are urgently needed to detect new antibiotics. One such strategy uses known ubiquitous targets like DNA topoisomerases. However, to detect inhibitors of these enzymes by an in vitro assay time-consuming isolation of enzymes and DNA followed by electrophoretic separation of topoisomers are required. Instead, this study aimed at developing an in vivo assay for the detection of alterations in DNA supercoiling indicative of topoisomerase inhibition by a reporter gene assay. A pair of plasmids was developed which carry the reporter gene luc for firefly luciferase under control of either promoter ptopA (pPHB90) or pgyrA (pPHB91), whose activities are reciprocally affected by alterations of the supercoiling degree. Each plasmid is individually transferred into E. coli cells. The quotient of the luciferase activities determined using cells with either plasmid was taken as relative measure of the global supercoiling degree Qsc (quotient of supercoiling). Using isogenic reference strains with known alterations of the global DNA supercoiling degree due to mutations in either gyrB or topA, the reporter gene system was able to detect both a decrease and an increase of the negative supercoiling degree compared to the isogenic parent strain. Treating cells with known inhibitors of DNA gyrase, like fluoroquinolones, novobiocin as well as simocyclinone D8 from Streptomyces antibioticus which has been identified as an inhibitor of DNA gyrase in vitro, also caused decreases of the Qsc value in vivo. The suitability of this reporter gene system to screen for anti-topoisomerase I and II compounds from various natural sources like plant extracts by sensing alterations of the DNA supercoiling was demonstrated and offers a new application to identify novel compounds active against bacterial topoisomerases I and gyrase.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23923635

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  4 in total

Review 1.  Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.

Authors:  Yuk-Ching Tse-Dinh
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

2.  Supercoiling Effects on Short-Range DNA Looping in E. coli.

Authors:  Lauren S Mogil; Nicole A Becker; L James Maher
Journal:  PLoS One       Date:  2016-10-26       Impact factor: 3.240

3.  Upregulation of the PatAB Transporter Confers Fluoroquinolone Resistance to Streptococcus pseudopneumoniae.

Authors:  María Alvarado; Antonio J Martín-Galiano; María J Ferrándiz; Ángel Zaballos; Adela G de la Campa
Journal:  Front Microbiol       Date:  2017-10-26       Impact factor: 5.640

4.  Dependence of DNA looping on Escherichia coli culture density.

Authors:  Justin P Peters; Vishwas N Rao; Nicole A Becker; L James Maher
Journal:  Int J Biochem Mol Biol       Date:  2019-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.